Perrigo Company plc provides over-the-counter (OTC) health and wellness solutions aimed at enabling consumers to manage their health independently. The company operates through two segments: Consumer Self-Care Americas and Consumer Self-Care International. The Americas segment generates approximately 60-70% of revenue by offering store brand self-care products across various categories, including pain relief, digestive health, and skincare. The International segment contributes about 30-40% of revenue through similar products in around 23 countries, primarily in Europe. Factors supporting endurance include a long history in the industry and a diverse product portfolio, while challenges may arise from competition and regulatory pressures in the healthcare sector.
—
Perrigo Company plc provides over-the-counter (OTC) health and wellness solutions aimed at enabling consumers to manage their health independently. The company operates through two segments: Consumer Self-Care Americas and Consumer Self-Care International. The Americas segment generates approximately 60-70% of revenue by offering store brand self-care products across various categories, including pain relief, digestive health, and skincare. The International segment contributes about 30-40% of revenue through similar products in around 23 countries, primarily in Europe. Factors supporting endurance include a long history in the industry and a diverse product portfolio, while challenges may arise from competition and regulatory pressures in the healthcare sector.
—
Daily adjusted close
Perrigo Company plc provides over-the-counter (OTC) health and wellness solutions aimed at enabling consumers to manage their health independently. The company operates through two segments: Consumer Self-Care Americas and Consumer Self-Care International. The Americas segment generates approximately 60-70% of revenue by offering store brand self-care products across various categories, including pain relief, digestive health, and skincare. The International segment contributes about 30-40% of revenue through similar products in around 23 countries, primarily in Europe. Factors supporting endurance include a long history in the industry and a diverse product portfolio, while challenges may arise from competition and regulatory pressures in the healthcare sector.